Cite

HARVARD Citation

    Bermel, R. et al. (2021). Safety evaluation of shorter infusion for ocrelizumab in a substudy of the Phase IIIb CHORDS trial. Annals of clinical and translational neurology. 8 (3), pp. 711-715. [Online]. 
  
Back to record